Anthony M. Magliocco

10.7k total citations · 1 hit paper
136 papers, 4.2k citations indexed

About

Anthony M. Magliocco is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Anthony M. Magliocco has authored 136 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 47 papers in Molecular Biology and 44 papers in Cancer Research. Recurrent topics in Anthony M. Magliocco's work include Cancer Genomics and Diagnostics (17 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Breast Cancer Treatment Studies (11 papers). Anthony M. Magliocco is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Breast Cancer Treatment Studies (11 papers). Anthony M. Magliocco collaborates with scholars based in Canada, United States and United Kingdom. Anthony M. Magliocco's co-authors include Linda S. Cook, Alexander C. Klimowicz, Mauro Tambasco, John B. McIntyre, Susan P. Lees‐Miller, Corinne Doll, Christine M. Friedenreich, Glòria Roldán, Stephanie Petrillo and Kerry S. Courneya and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Anthony M. Magliocco

129 papers receiving 4.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer

2019 352 citations Anthony M. Magliocco et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anthony M. Magliocco Canada	38	1.8k	1.3k	1.1k	853	501	136	4.2k
Flora Zagouri Greece	33	1.7k 1.0×	1.2k 0.9×	718 0.7×	873 1.0×	241 0.5×	301	4.0k
Federica Tomao Italy	38	2.0k 1.1×	1.2k 0.9×	1.0k 0.9×	731 0.9×	365 0.7×	243	4.9k
Nicolaì Maass Germany	33	1.8k 1.0×	1.3k 1.0×	773 0.7×	1.1k 1.3×	427 0.9×	274	4.9k
Ondřej Topolčan Czechia	31	1.6k 0.9×	1.3k 1.0×	1.0k 1.0×	1.1k 1.3×	278 0.6×	254	4.2k
Nam Hoon Cho South Korea	38	1.3k 0.7×	1.8k 1.3×	1.2k 1.2×	991 1.2×	354 0.7×	223	4.9k
Christian F. Singer Austria	45	3.0k 1.7×	2.0k 1.5×	983 0.9×	2.1k 2.4×	817 1.6×	267	6.4k
Stefania Staibano Italy	43	2.4k 1.4×	2.8k 2.1×	1.2k 1.1×	689 0.8×	308 0.6×	229	6.5k
Dinesh Rakheja United States	42	707 0.4×	2.9k 2.2×	1.3k 1.2×	1.3k 1.5×	531 1.1×	188	6.0k
Megan L. Troxell United States	36	1.5k 0.8×	1.3k 0.9×	1.2k 1.1×	699 0.8×	556 1.1×	141	4.3k
Zhen‐Yu He China	28	1.2k 0.7×	874 0.6×	755 0.7×	1.0k 1.2×	250 0.5×	180	3.3k

Countries citing papers authored by Anthony M. Magliocco

Since Specialization

Citations

This map shows the geographic impact of Anthony M. Magliocco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony M. Magliocco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony M. Magliocco more than expected).

Fields of papers citing papers by Anthony M. Magliocco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony M. Magliocco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony M. Magliocco. The network helps show where Anthony M. Magliocco may publish in the future.

Co-authorship network of co-authors of Anthony M. Magliocco

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony M. Magliocco. A scholar is included among the top collaborators of Anthony M. Magliocco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony M. Magliocco. Anthony M. Magliocco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Magliocco, Anthony M., et al.. (2025). Cannabinoid Hyperemesis Syndrome: A Rising Complication. Cureus. 17(2). e78958–e78958.

Brockton, Nigel T., Linda S. Cook, Anthony M. Magliocco, et al.. (2025). The Breast to Bone (B2B) Cohort Study to Prevent, Detect and Improve Treatment of Metastatic Disease: Baseline Assessment, Description and Progress. International Journal of Environmental Research and Public Health. 22(2). 242–242. 1 indexed citations

Love, Tara M., Lara E. Sucheston‐Campbell, Michael Clark, et al.. (2024). Comparing Classifications from Multiple Variant Annotation Software Solutions Using Real-World Next Generation Sequencing Data from Oncology Testing. SHILAP Revista de lepidopterología. 5(1). 81–95.

Marchion, Douglas C., Susan McCarthy, Ardeshir Hakam, et al.. (2021). Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes. PLoS ONE. 16(11). e0256615–e0256615. 3 indexed citations

Napoli, Marco, Zheng‐Xiang Li, Marlese A. Pisegna, et al.. (2020). Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation. Nature Communications. 11(1). 15 indexed citations

Cao, Yu, Jimena Trillo-Tinoco, Rosa A. Sierra, et al.. (2019). ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nature Communications. 10(1). 1280–1280. 111 indexed citations

Law, Vincent, Brittany Evernden, Rajappa S. Kenchappa, et al.. (2018). EXTH-39. DETECTION, MOLECULAR PROFILING AND CULTURE OF CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) IN MELANOMA TO IMPROVE DIAGNOSIS AND TREATMENT STRATEGIES. Neuro-Oncology. 20(suppl_6). vi93–vi93. 1 indexed citations

Enwere, Emeka K., Elizabeth Kornaga, Michelle L. Dean, et al.. (2017). Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer. Modern Pathology. 30(4). 577–586. 145 indexed citations

Lawrence, Yaacov Richard, Jennifer Moughan, Anthony M. Magliocco, et al.. (2017). Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704. Cancer. 124(3). 491–498. 8 indexed citations

10.

Permuth‐Wey, Jennifer, Dung‐Tsa Chen, William J. Fulp, et al.. (2015). Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas. Cancer Prevention Research. 8(9). 826–834. 41 indexed citations

11.

Cavallone, Luca, Aline Mamo, Catherine Chabot, et al.. (2015). The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers. Cancer Research. 75(20). 4351–4363. 41 indexed citations

12.

Feng, Xiaolan, Haocheng Li, Michelle L. Dean, et al.. (2015). Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer. Breast Cancer Research. 17(1). 65–65. 32 indexed citations

13.

Xiong, Yin, Douglas C. Marchion, Forough Abbasi, et al.. (2015). Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance. Gynecologic Oncology. 140(2). 259–263. 16 indexed citations

14.

Nelson, Gregg, et al.. (2013). Precursor Lesions and Prognostic Factors in Primary Peritoneal Serous Carcinoma. International Journal of Gynecological Pathology. 32(6). 547–555. 10 indexed citations

15.

Hanna, Wedad, Penny J. Barnes, Richard Berendt, et al.. (2012). Testing for HER2 in Breast Cancer: Current Pathology Challenges Faced in Canada. Current Oncology. 19(6). 315–323. 10 indexed citations

16.

Friedenreich, Christine M., David C.W. Lau, Kerry S. Courneya, et al.. (2012). Case–control study of markers of insulin resistance and endometrial cancer risk. Endocrine Related Cancer. 19(6). 785–792. 38 indexed citations

17.

Doll, Corinne, Kathryn Winter, David K. Gaffney, et al.. (2012). COX-2 Expression and Survival in Patients With Locally Advanced Cervical Cancer Treated With Chemoradiotherapy and Celecoxib. International Journal of Gynecological Cancer. 23(1). 176–183. 13 indexed citations

18.

Rimm, David L., Torsten O. Nielsen, Scott D. Jewell, et al.. (2011). Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues. Journal of Clinical Oncology. 29(16). 2282–2290. 21 indexed citations

19.

Drabycz, Sylvia, Glòria Roldán, Paula de Robles, et al.. (2009). An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. NeuroImage. 49(2). 1398–1405. 160 indexed citations

20.

Tambasco, Mauro, et al.. (2008). Quantifying the architectural complexity of microscopic images of histology specimens. Micron. 40(4). 486–494. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact